{
    "clinical_study": {
        "@rank": "13181", 
        "arm_group": [
            {
                "arm_group_label": "Hysterectomy", 
                "arm_group_type": "No Intervention", 
                "description": "Hysterectomy without oophorectomy or salpingectomy"
            }, 
            {
                "arm_group_label": "Hysterctomy with salpingectomy or fimbriectomy", 
                "arm_group_type": "Experimental", 
                "description": "Salpingectomy or Fimbriectomy"
            }
        ], 
        "brief_summary": {
            "textblock": "The impact of Hysterectomy with preservation of the ovaries on ovarian function has long\n      been controversial. studies have shown conflicting data regarding ovarian function after\n      simple Hysterectomy.\n\n      In recent years, there is a growing evidence that Salpingectomy or Fimbriectomy may have\n      preventive value reducing Ovarian and Primary Peritoneal carcinoma, but the safety and the\n      consequences regarding ovarian function have yet to be established.\n\n      The aim of this study is to evaluate ovarian function after Hysterectomy alone Vs.\n      Hysterectomy combined with salpingectomy or fimbriectomy"
        }, 
        "brief_title": "Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy", 
        "condition": "Ovarian Function Insufficiency", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women undergoing Hysterectomy for Benign In dication (eg. Uterus Myomatous) before\n             menopause\n\n        Exclusion Criteria:\n\n          -  Menopause\n\n          -  known or suspected malignancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782807", 
            "org_study_id": "kmc0029-11"
        }, 
        "intervention": {
            "arm_group_label": "Hysterctomy with salpingectomy or fimbriectomy", 
            "intervention_name": "Salpingectomy or Fimbriectomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Ovarian function", 
            "Hysterectomy", 
            "Salpingectomy", 
            "Anti mullerian hormone"
        ], 
        "lastchanged_date": "January 31, 2013", 
        "location": {
            "contact": {
                "email": "abenarie@hotmail.com", 
                "last_name": "Alon Ben- Arie, MD"
            }, 
            "contact_backup": {
                "email": "yaelnaa@gmail.com", 
                "last_name": "Yael Naaman, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Rehovot", 
                    "country": "Israel"
                }, 
                "name": "Kaplan Medical Center"
            }, 
            "investigator": {
                "last_name": "Alon Ben- Arie, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy", 
        "overall_contact": {
            "email": "abenarie@hotmail.com", 
            "last_name": "Alon Ben- Arie, MD", 
            "phone": "00-972-50-2460001"
        }, 
        "overall_contact_backup": {
            "email": "yaelnaa@gmail.con", 
            "last_name": "Yael Naaman, MD", 
            "phone": "00-972-52-3499377"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "ovarian function measured by FSH , AMH and follicule count on ultra-sound", 
            "measure": "Ovarian function", 
            "safety_issue": "No", 
            "time_frame": "60 days post-operative"
        }, 
        "reference": [
            {
                "PMID": "7409710", 
                "citation": "Maseela T, Scheele R. [Hysterosalpingectomy. A contribution to the prevention of primary tubal neoplasms]. Fortschr Med. 1980 Jun 5;98(21):818-22. German."
            }, 
            {
                "PMID": "9175692", 
                "citation": "Zalel Y, Lurie S, Beyth Y, Goldberger S, Tepper R. Is it necessary to perform a prophylactic oophorectomy during hysterectomy? Eur J Obstet Gynecol Reprod Biol. 1997 May;73(1):67-70."
            }, 
            {
                "PMID": "12501050", 
                "citation": "Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol. 2002 Dec;187(6):1483-5; discussion 1485-6."
            }, 
            {
                "PMID": "15957999", 
                "citation": "Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG. 2005 Jul;112(7):956-62."
            }, 
            {
                "PMID": "3746790", 
                "citation": "Riedel HH, Lehmann-Willenbrock E, Semm K. Ovarian failure phenomena after hysterectomy. J Reprod Med. 1986 Jul;31(7):597-600."
            }, 
            {
                "PMID": "11788175", 
                "citation": "Bulent Tiras M, Noyan V, Ozdemir H, Guner H, Yildiz A, Yildirim M. The changes in ovarian hormone levels and ovarian artery blood flow rate after laparoscopic tubal sterilization. Eur J Obstet Gynecol Reprod Biol. 2001 Dec 1;99(2):219-21."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782807"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kaplan Medical Center", 
            "investigator_full_name": "Lion Poles", 
            "investigator_title": "Deputy Director of Kaplan Medical Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Kaplan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kaplan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2011"
    }
}